Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Apathy and lack of motivation are symptoms of cancer cachexia, research suggests April 10, 2025 A sharp rise in “very short sleep” among US teens March 4, 2026 Optimized fermentation process unlocks anti-aging potential of tapuy lees March 15, 2025